Researchers develop nasal spray H5N1 avian influenza vaccine
The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Center for ...
AI-powered Cancer Vaccine In The Works
RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.
Vietnam Investment Reviev10d
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates
Industry insiders believe that AI is crucial in the mRNA field. Particularly in vaccine design, anticipating future mutation ...
BioSpace3d
Beyond Black Box: How Data-Driven AI Is Transforming RNA Medicine Development
While AI offers remarkable efficiency, the pharmaceutical industry must address concerns about “black box” predictions – AI ...
CURE9d
New Cancer Vaccine, EVM14, Cleared for Investigational Drug Application
EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...
Gennova Biopharma partners with CEPI to develop mRNA Nipah vaccine
Nipah virus, a highly lethal pathogen belonging to the Paramyxovirus family, has caused multiple outbreaks in South and ...
Devdiscourse3d
TechInvention Taps Belgian Expertise for mRNA Vaccine Revolution
TechInvention and Belgium-based Quantoom Biosciences have entered a partnership to enhance the local manufacturing of mRNA ...
Pune-based Gennova Biopharmaceuticals secures US$ 13.38 million funding to develop Nipah virus vaccine
Dr Sanjay Singh, CEO of Gennova Biopharmaceuticals, said the firm will do preclinical and phase 1 vaccine tests in India, ...
Yahoo Finance11d
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates
HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA ...
Yahoo Finance11d
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates
2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has ...